ACADM and heart failure: To confirm this result, MCAD activity was found decreased in the LV, IFM and SSM in heart failure, although MitoQ did not restore the activity of this enzyme, the activity of MCAD in SSM from heart failure group treated with MitoQ was not reduced as compared to SHAM.